There is hope that a new drug can slow the progression of Parkinson's disease and, in doing so, be the only medication to do so, it has been announced.
Scientists based at the University of South Florida in Tampa this week announced results from their most recent research project, entitled Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease.
Robert A Hauser, the director of the Parkinson's Disease and Movement Disorders Clinic and author of the report, announced that the administering of rasagiline resulted in a 16 per cent slowdown in Parkinson's disease progression.
He continued: "Patients who received rasagiline right from the beginning rather than after a six-month delay experienced less progression of the clinical signs and symptoms of Parkinson's disease that interfere with activities of daily living such as eating, walking and dressing."
The USF Medical Center was established in 1965 and enrolled its charter class in 1971.
Please click here for advice to help you find the right type of care.